Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-076049

Chairman & CEO bought 4,000 shares at an average $11.64 ($46,540)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-28 Purchase : show line 1 in the form +300 $11.82 $3,546 2,964,614 D
2022-06-29 Purchase : show line 2 in the form +3,700 $11.62 $42,994 2,968,314 D
Open-market purchases · 4,000 sh · avg $11.64 · $46,540
Loading xslF345X03/tm2220119-1_4seq1.xml…